was read the article
array:25 [ "pii" => "S2013251418301123" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2018.10.005" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "479" "copyright" => "Sociedad Española de Nefrología" "copyrightAnyo" => "2018" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Nefrologia (English Version). 2018;38:476-90" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4022 "formatos" => array:3 [ "EPUB" => 185 "HTML" => 2796 "PDF" => 1041 ] ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0211699518300444" "issn" => "02116995" "doi" => "10.1016/j.nefro.2017.12.006" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "479" "copyright" => "Sociedad Española de Nefrología" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Nefrologia. 2018;38:476-90" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 8787 "formatos" => array:3 [ "EPUB" => 353 "HTML" => 6909 "PDF" => 1525 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Revisión</span>" "titulo" => "Osteoporosis, densidad mineral ósea y complejo CKD-MBD (I): consideraciones diagnósticas" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "476" "paginaFinal" => "490" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figura 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1273 "Ancho" => 3161 "Tamanyo" => 181268 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Cálculo de probabilidad de fractura con ayuda de FRAX® (fracture probability según los factores de riesgo [CRF]). Los niveles de riesgo de fractura altos (<span class="elsevierStyleItalic">high</span>), intermedios (<span class="elsevierStyleItalic">intermediate</span>) y bajos (<span class="elsevierStyleItalic">low</span>) son variables según guías y países. En Estados Unidos y Reino Unido se considera que un riesgo de fractura mayor osteoporótica a los 10 años ≥ 20% o un riesgo de fractura de cadera ≥ 3% es elevado, 10-20% como riesgo intermedio (aconsejaría densitometría [BMD, <span class="elsevierStyleItalic">bone mineral density</span>] y recálculo) y < 10% como riesgo bajo (cifras basadas en coste-efectividad). Algunas guías (ver <a class="elsevierStyleCrossRef" href="#fig0020">fig. 4</a>) recomiendan recalcular FRAX <span class="elsevierStyleItalic">(reassess probability)</span> con DMO tanto para los pacientes con riesgo intermedio como elevado para tartar (<span class="elsevierStyleItalic">treat</span>) (la DMO también servirá para valorar la respuesta al tratamiento)<a class="elsevierStyleCrossRef" href="#bib0890"><span class="elsevierStyleSup">26</span></a>.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jordi Bover, Pablo Ureña-Torres, Josep-Vicent Torregrosa, Minerva Rodríguez-García, Cristina Castro-Alonso, José Luis Górriz, Ana María Laiz Alonso, Secundino Cigarrán, Silvia Benito, Víctor López-Báez, María Jesús Lloret Cora, Iara daSilva, Jorge Cannata-Andía" "autores" => array:13 [ 0 => array:2 [ "nombre" => "Jordi" "apellidos" => "Bover" ] 1 => array:2 [ "nombre" => "Pablo" "apellidos" => "Ureña-Torres" ] 2 => array:2 [ "nombre" => "Josep-Vicent" "apellidos" => "Torregrosa" ] 3 => array:2 [ "nombre" => "Minerva" "apellidos" => "Rodríguez-García" ] 4 => array:2 [ "nombre" => "Cristina" "apellidos" => "Castro-Alonso" ] 5 => array:2 [ "nombre" => "José Luis" "apellidos" => "Górriz" ] 6 => array:2 [ "nombre" => "Ana María" "apellidos" => "Laiz Alonso" ] 7 => array:2 [ "nombre" => "Secundino" "apellidos" => "Cigarrán" ] 8 => array:2 [ "nombre" => "Silvia" "apellidos" => "Benito" ] 9 => array:2 [ "nombre" => "Víctor" "apellidos" => "López-Báez" ] 10 => array:2 [ "nombre" => "María Jesús" "apellidos" => "Lloret Cora" ] 11 => array:2 [ "nombre" => "Iara" "apellidos" => "daSilva" ] 12 => array:2 [ "nombre" => "Jorge" "apellidos" => "Cannata-Andía" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2013251418301123" "doi" => "10.1016/j.nefroe.2018.10.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418301123?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699518300444?idApp=UINPBA000064" "url" => "/02116995/0000003800000005/v1_201810110611/S0211699518300444/v1_201810110611/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S2013251418301081" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2018.10.001" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "490" "copyright" => "Sociedad Española de Nefrología" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2018;38:491-502" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1777 "formatos" => array:3 [ "EPUB" => 179 "HTML" => 1005 "PDF" => 593 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "The anaemia control model: Does it help nephrologists in therapeutic decision-making in the management of anaemia?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "491" "paginaFinal" => "502" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "El modelo de control de anemia: ¿ayuda al nefrólogo en la decisión terapéutica para el manejo de la anemia?" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María Laura Bucalo, Carlo Barbieri, Susana Roca, Jasmine Ion Titapiccolo, Maria Soledad Ros Romero, Rosa Ramos, Mercedes Albaladejo, Diana Manzano, Flavio Mari, Manuel Molina" "autores" => array:10 [ 0 => array:2 [ "nombre" => "María Laura" "apellidos" => "Bucalo" ] 1 => array:2 [ "nombre" => "Carlo" "apellidos" => "Barbieri" ] 2 => array:2 [ "nombre" => "Susana" "apellidos" => "Roca" ] 3 => array:2 [ "nombre" => "Jasmine" "apellidos" => "Ion Titapiccolo" ] 4 => array:2 [ "nombre" => "Maria Soledad" "apellidos" => "Ros Romero" ] 5 => array:2 [ "nombre" => "Rosa" "apellidos" => "Ramos" ] 6 => array:2 [ "nombre" => "Mercedes" "apellidos" => "Albaladejo" ] 7 => array:2 [ "nombre" => "Diana" "apellidos" => "Manzano" ] 8 => array:2 [ "nombre" => "Flavio" "apellidos" => "Mari" ] 9 => array:2 [ "nombre" => "Manuel" "apellidos" => "Molina" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699518300687" "doi" => "10.1016/j.nefro.2018.03.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699518300687?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418301081?idApp=UINPBA000064" "url" => "/20132514/0000003800000005/v1_201811140611/S2013251418301081/v1_201811140611/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2013251418301032" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2018.07.005" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "467" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Nefrologia (English Version). 2018;38:466-75" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2885 "formatos" => array:3 [ "EPUB" => 225 "HTML" => 2010 "PDF" => 650 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Could the Notch signaling pathway be a potential therapeutic option in renal diseases?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "466" "paginaFinal" => "475" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Análisis de la vía Notch como una posible diana terapéutica en la patología renal" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1023 "Ancho" => 2795 "Tamanyo" => 98394 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Regulation of the Notch pathway by miRNA.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Laura Marquez-Exposito, Elena Cantero-Navarro, Carolina Lavoz, Marta Fierro-Fernández, Jonay Poveda, Sandra Rayego-Mateos, Raúl R. Rodrigues-Diez, José Luis Morgado-Pascual, Macarena Orejudo, Sergio Mezzano, Marta Ruiz-Ortega" "autores" => array:11 [ 0 => array:2 [ "nombre" => "Laura" "apellidos" => "Marquez-Exposito" ] 1 => array:2 [ "nombre" => "Elena" "apellidos" => "Cantero-Navarro" ] 2 => array:2 [ "nombre" => "Carolina" "apellidos" => "Lavoz" ] 3 => array:2 [ "nombre" => "Marta" "apellidos" => "Fierro-Fernández" ] 4 => array:2 [ "nombre" => "Jonay" "apellidos" => "Poveda" ] 5 => array:2 [ "nombre" => "Sandra" "apellidos" => "Rayego-Mateos" ] 6 => array:2 [ "nombre" => "Raúl R." "apellidos" => "Rodrigues-Diez" ] 7 => array:2 [ "nombre" => "José Luis" "apellidos" => "Morgado-Pascual" ] 8 => array:2 [ "nombre" => "Macarena" "apellidos" => "Orejudo" ] 9 => array:2 [ "nombre" => "Sergio" "apellidos" => "Mezzano" ] 10 => array:2 [ "nombre" => "Marta" "apellidos" => "Ruiz-Ortega" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699518300158" "doi" => "10.1016/j.nefro.2017.11.027" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699518300158?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418301032?idApp=UINPBA000064" "url" => "/20132514/0000003800000005/v1_201811140611/S2013251418301032/v1_201811140611/en/main.assets" ] "en" => array:21 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Osteoporosis, bone mineral density and CKD–MBD complex (I): Diagnostic considerations" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "476" "paginaFinal" => "490" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Jordi Bover, Pablo Ureña-Torres, Josep-Vicent Torregrosa, Minerva Rodríguez-García, Cristina Castro-Alonso, José Luis Górriz, Ana María Laiz Alonso, Secundino Cigarrán, Silvia Benito, Víctor López-Báez, María Jesús Lloret Cora, Iara daSilva, Jorge Cannata-Andía" "autores" => array:13 [ 0 => array:4 [ "nombre" => "Jordi" "apellidos" => "Bover" "email" => array:1 [ 0 => "jbover@fundacio-puigvert.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Pablo" "apellidos" => "Ureña-Torres" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Josep-Vicent" "apellidos" => "Torregrosa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Minerva" "apellidos" => "Rodríguez-García" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "Cristina" "apellidos" => "Castro-Alonso" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "José Luis" "apellidos" => "Górriz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "Ana María" "apellidos" => "Laiz Alonso" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 7 => array:3 [ "nombre" => "Secundino" "apellidos" => "Cigarrán" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">h</span>" "identificador" => "aff0040" ] ] ] 8 => array:3 [ "nombre" => "Silvia" "apellidos" => "Benito" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 9 => array:3 [ "nombre" => "Víctor" "apellidos" => "López-Báez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 10 => array:3 [ "nombre" => "María Jesús" "apellidos" => "Lloret Cora" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 11 => array:3 [ "nombre" => "Iara" "apellidos" => "daSilva" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 12 => array:3 [ "nombre" => "Jorge" "apellidos" => "Cannata-Andía" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] ] ] ] "afiliaciones" => array:9 [ 0 => array:3 [ "entidad" => "Fundació Puigvert, Servicio de Nefrología, IIB Sant Pau, REDinREN, Barcelona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Ramsay-Générale de Santé, Clinique du Landy, Department of Nephrology and Dialysis and Department of Renal Physiology, Necker Hospital, University of Paris Descartes, París, France" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Nefrología, Hospital Clinic, IDIBAPS, Universidad de Barcelona, Barcelona, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Nefrología, Hospital Universitario Central de Asturias, REDinREN, Universidad de Oviedo, Oviedo, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Nefrología, Hospital Dr. Peset, Valencia, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Nefrología, Hospital Clínico Universitario de Valencia, INCLIVA, Universidad de Valencia, Valencia, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Reumatología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Servicio de Nefrología, Hospital da Costa de Burela, Lugo, Spain" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "Unidad de Gestión Clínica de Servicio de Metabolismo Óseo, Hospital Universitario Central de Asturias, Instituto de Investigación del Principado de Asturias, REDinREN, Universidad de Oviedo, Oviedo, Spain" "etiqueta" => "i" "identificador" => "aff0045" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Osteoporosis, densidad mineral ósea y complejo CKD-MBD (I): consideraciones diagnósticas" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Fig. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1591 "Ancho" => 1583 "Tamanyo" => 156490 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Decision tree based on the most cost-effective option in the Spanish FRIDEX cohort of Spanish women (general population) who did not receive treatment during the 10 years of follow-up.<a class="elsevierStyleCrossRef" href="#bib0995"><span class="elsevierStyleSup">47</span></a> DXA or DEXA: Dual-Energy X-ray absorptiometry; OP: osteoporosis.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Osteoporosis (OP) is the most common skeletal disorder in the general population,<a class="elsevierStyleCrossRef" href="#bib0765"><span class="elsevierStyleSup">1</span></a> and is characterised by a loss of bone strength associated with an increased risk of low-impact fractures and their negative consequences.<a class="elsevierStyleCrossRefs" href="#bib0770"><span class="elsevierStyleSup">2–4</span></a> Bone strength is determined not only by bone mineral <span class="elsevierStyleItalic">density</span> (BMD), but also by bone <span class="elsevierStyleItalic">quality</span><a class="elsevierStyleCrossRefs" href="#bib0770"><span class="elsevierStyleSup">2–4</span></a> (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). However, OP is usually diagnosed on the basis of BMD below a predetermined and arbitrary level (<span class="elsevierStyleItalic">T-score</span><span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>−2.5 standard deviations) measured by “Dual-energy X-ray Absorptiometry” (DEXA), without taking into account bone quality.<a class="elsevierStyleCrossRefs" href="#bib0770"><span class="elsevierStyleSup">2,5</span></a> It is important to emphasise that the BMD value is an important risk factor for fracture, and that a large proportion of fractures in the general population occur in individuals with <span class="elsevierStyleItalic">osteopenia</span>,<a class="elsevierStyleCrossRef" href="#bib0790"><span class="elsevierStyleSup">6</span></a> so it is also essential to assess other non-densitometric risk factors (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).<a class="elsevierStyleCrossRefs" href="#bib0795"><span class="elsevierStyleSup">7–10</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">On the other hand, chronic kidney disease (CKD) is known to have an important impact on bone health, as defined in the classical concept of “renal osteodystrophy” (ROD).<a class="elsevierStyleCrossRefs" href="#bib0815"><span class="elsevierStyleSup">11,12</span></a> Currently, the term ROD should be used exclusively to define <span class="elsevierStyleItalic">histological</span> lesions observed in bone biopsies in patients with CKD (one of the components of the “Chronic Kidney Disease–Mineral and Bone Disorder” (CKD–MBD) complex,<a class="elsevierStyleCrossRef" href="#bib0825"><span class="elsevierStyleSup">13</span></a> which includes Turnover, Mineralization and Volume -TMV- abnormalities).<a class="elsevierStyleCrossRefs" href="#bib0800"><span class="elsevierStyleSup">8,11,12</span></a> ROD includes diseases with high bone remodelling, such as osteitis fibrosa (reflecting secondary hyperparathyroidism), low bone remodelling (such as osteomalacia or adynamic bone disease [ABD]), and mixed forms, among others. OP, meanwhile, involves a loss of bone mass and changes in microarchitecture not associated with a specific mineralisation, cellularity or bone turnover defect.<a class="elsevierStyleCrossRefs" href="#bib0830"><span class="elsevierStyleSup">14,15</span></a> Therefore, although OP and ABD share some common <span class="elsevierStyleItalic">clinical</span> characteristics, their pathogenesis, histopathology and treatment are different.<a class="elsevierStyleCrossRefs" href="#bib0830"><span class="elsevierStyleSup">14,16</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">There is a fast-growing body of evidence that patients with CKD have a higher risk of fracture (and associated mortality) than the general population, probably because the mechanical properties of the bone are additionally affected by intrinsic “uremic factors” specific to CKD. This has led to the introduction of a new concept “uraemic OP”,<a class="elsevierStyleCrossRef" href="#bib0845"><span class="elsevierStyleSup">17</span></a> which emphasises the particularly complex relationship between BMD and the risk of fracture and mortality in CKD patients, since this population is also exposed to “classic” age- or gender-related OP even before the diagnosis of CKD.<a class="elsevierStyleCrossRef" href="#bib0845"><span class="elsevierStyleSup">17</span></a> For this reason, nephrologists must, on the one hand, gain further insight into the risk factors for OP and fracture, and, on the other, promote the diagnostic criteria of the classic form of OP. We should also highlight the importance of CKD in the differential diagnosis of patients with OP, in light of the therapeutic implications that will be analysed in the second part of this review.<a class="elsevierStyleCrossRef" href="#bib0850"><span class="elsevierStyleSup">18</span></a> In fact, secondary hyperparathyroidism characteristic of CKD is most probably not the primary cause of fractures,<a class="elsevierStyleCrossRefs" href="#bib0845"><span class="elsevierStyleSup">17,19</span></a> and loss of BMD associated with population ageing, sex hormone changes and other secondary causes should be considered, irrespective of the loss associated with CKD or ROD itself.<a class="elsevierStyleCrossRefs" href="#bib0845"><span class="elsevierStyleSup">17,19–21</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">For all these reasons, in the first part of this review we will analyse in detail both the evaluation of fracture risk in the general population and in CKD patients, and the possible indications of DEXA, given its diagnostic implications in CKD. Biochemical parameters (biomarkers) and the use (infrequent and sometimes limiting) of bone biopsy will also be analysed.</p><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">General concepts of osteoporosis, risk factors and clinical consequences</span><p id="par0025" class="elsevierStylePara elsevierViewall">Osteoporotic or fragility fractures (spontaneous or caused by minimal trauma [such as a fall from the same height]) are a significant public health problem due to their high prevalence, morbidity and mortality, and increasing consumption of resources.<a class="elsevierStyleCrossRefs" href="#bib0870"><span class="elsevierStyleSup">22–25</span></a> For this reason, various agencies<a class="elsevierStyleCrossRef" href="#bib0885"><span class="elsevierStyleSup">25</span></a> recommend <span class="elsevierStyleItalic">evaluating</span> the presence of <span class="elsevierStyleItalic">fracture risk factors</span> (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>) on an individual basis, and discourage universal densitometry screening.<a class="elsevierStyleCrossRefs" href="#bib0775"><span class="elsevierStyleSup">3,26–29</span></a> Risk factors should be evaluated whenever there is clinical suspicion, and perhaps also, ideally, in all patients with CKD, regardless of age. On the other hand, <span class="elsevierStyleItalic">quantification</span> of fracture risk in the general population can be performed using different scales, the best known being the Fracture Risk Assessment Tool (FRAX<span class="elsevierStyleSup">®</span>) (<a id="intr0015" class="elsevierStyleInterRef" href="http://www.shef.ac.uk/FRAX">www.shef.ac.uk/FRAX</a>) (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>). The FRAX<span class="elsevierStyleSup">®</span> algorithm calculates the 10-year probability of major osteoporotic fracture (vertebral, forearm, hip or humerus) and/or hip fracture (without current or previous treatment). The scale has been translated and validated in various countries, and the score is merely <span class="elsevierStyleItalic">illustrative</span>, given its significant limitations (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>).<a class="elsevierStyleCrossRefs" href="#bib0810"><span class="elsevierStyleSup">10,30</span></a></p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">The FRAX<span class="elsevierStyleSup">®</span> algorithm does not include CKD, suggesting that this scale will underestimate the risk of fracture in our patients, especially in those with advanced CKD.<a class="elsevierStyleCrossRefs" href="#bib0915"><span class="elsevierStyleSup">31,32</span></a> Indeed, it is striking that a recently published set of American guidelines only include <span class="elsevierStyleItalic">terminal</span> CKD as a cause or contributor to OP and fractures.<a class="elsevierStyleCrossRef" href="#bib0925"><span class="elsevierStyleSup">33</span></a> In any event, although FRAX<span class="elsevierStyleSup">®</span> does not include adjustments for estimated glomerular filtration rate (eGFR), we believe that nephrologists could use this tool in a preliminary assessment, considering that the absolute value obtained probably underestimates the real risk of fracture. In fact, the presence of CKD is not only an important independent risk factor for fracture, but also increases the frequency of falls due to muscular weakness – sarcopenia or myoneuropathy.<a class="elsevierStyleCrossRefs" href="#bib0930"><span class="elsevierStyleSup">34–40</span></a> FRAX<span class="elsevierStyleSup">®</span> has been shown to discriminate and predict fractures in CKD or kidney transplant patients.<a class="elsevierStyleCrossRefs" href="#bib0965"><span class="elsevierStyleSup">41–43</span></a> For example, Jamal et al.,<a class="elsevierStyleCrossRef" href="#bib0965"><span class="elsevierStyleSup">41</span></a> reported that the discriminative capacity of BMD at the femoral neck was similar to FRAX<span class="elsevierStyleSup">®</span> for morphometric vertebral fractures and any fracture, with FRAX<span class="elsevierStyleSup">®</span> being superior for clinical non-vertebral fractures (0.66; [0.60–0.73]). Compared with FRAX<span class="elsevierStyleSup">®</span>, the area under the curve for age was <span class="elsevierStyleItalic">lower</span> in all types of fracture, but the best results were observed with FRAX<span class="elsevierStyleSup">®</span><span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>BMD.<a class="elsevierStyleCrossRef" href="#bib0965"><span class="elsevierStyleSup">41</span></a> Similarly, Naylor et al.<a class="elsevierStyleCrossRef" href="#bib0970"><span class="elsevierStyleSup">42</span></a> analysed 320 patients (67<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>10 years, 71% women) with eGFR<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>60<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span> and 1787 with eGFR<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>60<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span>. The observed risk of major clinical fracture due to OP was 5.3% (3.3–8.6%) in patients with eGFR<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>60<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span> (comparable to the FRAX<span class="elsevierStyleSup">®</span> estimate [6.4% with BMD and 8.2% without BMD]). No significant differences in prediction were observed in individuals with eGFR > or <60<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span>. In this study, FRAX<span class="elsevierStyleSup">®</span><span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>BMD, FRAX<span class="elsevierStyleSup">®</span> without BMD, and femoral neck BMD predicted fractures with an area under the curve of 0.65–0.71.<a class="elsevierStyleCrossRef" href="#bib0970"><span class="elsevierStyleSup">42</span></a> FRAX<span class="elsevierStyleSup">®</span> has also been assessed as a predictor of fracture in kidney transplant patients<a class="elsevierStyleCrossRef" href="#bib0975"><span class="elsevierStyleSup">43</span></a> and, recently, as a predictor of mortality in Japanese patients on dialysis.<a class="elsevierStyleCrossRef" href="#bib0980"><span class="elsevierStyleSup">44</span></a> Despite these positive findings, additional studies are needed before FRAX<span class="elsevierStyleSup">®</span> can be recommended in routine practice, particularly in stages 4–5D, since the presence of major changes in mineral metabolism (i.e. severe secondary hyperparathyroidism) or its treatment (vitamin D, phosphate binders) in these stages may be significant enough to affect the accuracy or adequacy of both FRAX<span class="elsevierStyleSup">®</span> and the criteria used for the diagnosis, prognosis or treatment of OP.</p><p id="par0035" class="elsevierStylePara elsevierViewall">After quantifying the fracture risk with FRAX<span class="elsevierStyleSup">®</span> (in the absence of a BMD measurement), patients are classified as low, intermediate or high risk (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>). <span class="elsevierStyleItalic">Low</span> risk patients should simply receive general advice (diet, exercise and re-evaluation at 5 years). <span class="elsevierStyleItalic">Intermediate</span> risk patients, depending on the country and resources available, are usually evaluated by densitometry to <span class="elsevierStyleItalic">recalculate</span> FRAX<span class="elsevierStyleSup">®</span> (including in this case BMD data). In the general population, active therapeutic intervention is advised in patients with high-risk FRAX<span class="elsevierStyleSup">®</span> and those whose re-evaluated risk falls above a certain threshold (i.e. >10% for major fractures and/or >3% for hip fracture, according to countries and authors) (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>). Given that FRAX<span class="elsevierStyleSup">®</span> appears to underestimate the risk of fracture in the Spanish cohort,<a class="elsevierStyleCrossRef" href="#bib0985"><span class="elsevierStyleSup">45</span></a> later studies have re-evaluated its usefulness in our general population,<a class="elsevierStyleCrossRefs" href="#bib0990"><span class="elsevierStyleSup">46,47</span></a> and densitometry/treatment is now advised in patients with >7.5% 10-year probability of major osteoporotic fracture (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>).</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><elsevierMultimedia ident="fig0020"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">Finally, we believe it is important to point out that an increasing number of studies have recognised the close link between vascular disease and bone pathology.<a class="elsevierStyleCrossRef" href="#bib1000"><span class="elsevierStyleSup">48</span></a> There is a significant inverse relationship between cardiovascular morbidity and mortality and BMD in both the general population and in CKD patients,<a class="elsevierStyleCrossRefs" href="#bib1005"><span class="elsevierStyleSup">49,50</span></a> and a similar inverse relationship between BMD and vascular calcification.<a class="elsevierStyleCrossRefs" href="#bib1000"><span class="elsevierStyleSup">48,51–54</span></a> The <span class="elsevierStyleItalic">paradox</span> of vascular calcification in the context of bone decalcification has been described in different pathologies.<a class="elsevierStyleCrossRef" href="#bib1035"><span class="elsevierStyleSup">55</span></a> Other studies have described the association of vascular calcification with a higher prevalence of vertebral fractures.<a class="elsevierStyleCrossRefs" href="#bib1040"><span class="elsevierStyleSup">56,57</span></a> Moreover, the prognostic value of these calcifications has been demonstrated using a simple lateral X-ray of the lumbar spine (<span class="elsevierStyleItalic">Kauppila</span> index) or of the hands and pelvis (<span class="elsevierStyleItalic">Adragao</span> index).<a class="elsevierStyleCrossRefs" href="#bib0800"><span class="elsevierStyleSup">8,58</span></a> Therefore, extending the lateral lumbar X-ray (suggested for the evaluation of aortic calcifications) to the <span class="elsevierStyleItalic">thoracic</span> region could be useful in the detection of asymptomatic vertebral fractures (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Epidemiology of fractures in chronic kidney disease</span><p id="par0045" class="elsevierStylePara elsevierViewall">Dialysis or transplant patients with CKD stages 1–5 have a much higher risk of suffering a fracture at any age compared with individuals of the same age and gender.<a class="elsevierStyleCrossRefs" href="#bib0880"><span class="elsevierStyleSup">24,37,59–62</span></a> Aside from the known risk of OP in patients with renal transplantation or treated with corticosteroids, there is increasing evidence of a reduction in both BMD and the mechanical properties of bone in patients with CKD stages 3a–5D.<a class="elsevierStyleCrossRefs" href="#bib1075"><span class="elsevierStyleSup">63–68</span></a> In a Canadian cohort of 679,114 adults aged ≥40, the cumulative incidence of peripheral and axial fractures increased gradually and significantly in adults in parallel with a decrease in eGFR in both genders and age groups (40–65/>65 years).<a class="elsevierStyleCrossRef" href="#bib0945"><span class="elsevierStyleSup">37</span></a> In stage 5, up to 10% of women and 5% of men experienced at least 1 fracture after 3 years of follow-up, with a similar trend in <span class="elsevierStyleItalic">falls</span> requiring hospitalisation.<a class="elsevierStyleCrossRef" href="#bib0945"><span class="elsevierStyleSup">37</span></a> In another recent study (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>10,955), both eGFR and albuminuria were significant risk factors for fracture.<a class="elsevierStyleCrossRef" href="#bib1105"><span class="elsevierStyleSup">69</span></a> All these data may be <span class="elsevierStyleItalic">underestimated</span>, since risk increases even in patients with relatively preserved renal function if cystatin C is used as a surrogate marker of renal function.<a class="elsevierStyleCrossRefs" href="#bib1110"><span class="elsevierStyleSup">70,71</span></a> Furthermore, the risk of fracture seems to increase even after <span class="elsevierStyleItalic">acute</span> deterioration of renal function that requires dialysis, despite almost complete recovery of renal function.<a class="elsevierStyleCrossRef" href="#bib1120"><span class="elsevierStyleSup">72</span></a> Finally, it should be noted that several longitudinal studies have confirmed the existence of an independent relationship between impaired renal function and <span class="elsevierStyleItalic">accelerated</span> BMD loss with age.<a class="elsevierStyleCrossRefs" href="#bib0935"><span class="elsevierStyleSup">35,73–76</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">In <span class="elsevierStyleItalic">dialysis</span> patients, several studies have also shown an increase in the incidence of fractures, especially of the hip.<a class="elsevierStyleCrossRefs" href="#bib1080"><span class="elsevierStyleSup">64–68,77–80</span></a> In an international cohort (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>34,579), Tentori et al. reported that 3% of participants presented with a fracture, although this incidence varied considerably among different countries (12/1000 patients-year in Japan; 40/1000 patients-year in Belgium and Sweden).<a class="elsevierStyleCrossRef" href="#bib1080"><span class="elsevierStyleSup">64</span></a> In this study, Spain presented the second <span class="elsevierStyleItalic">lowest</span> global incidence of fractures, although the incidence of hip fractures was similar to that of other European countries, suggesting that other fractures (such as vertebral) could have been underestimated. In any event, fractures were more frequent in the group of dialysis patients vs. the general population in all countries<a class="elsevierStyleCrossRef" href="#bib1080"><span class="elsevierStyleSup">64</span></a>, and non-vertebral fractures were always much more frequent than vertebral fractures.<a class="elsevierStyleCrossRefs" href="#bib1055"><span class="elsevierStyleSup">59–62</span></a> Age, female gender, hypoalbuminaemia, previous kidney transplantation, diabetes, cardiovascular disease or dementia have been found to be predictive factors,<a class="elsevierStyleCrossRefs" href="#bib1145"><span class="elsevierStyleSup">77,78,81</span></a> as well as taking selective serotonin reuptake inhibitors, narcotics and opiates, benzodiazepines, antiepileptic drugs and, of course, corticosteroids.<a class="elsevierStyleCrossRefs" href="#bib0865"><span class="elsevierStyleSup">21,77,78,81</span></a> Finally, a Danish study that collected data on almost all types of fracture<a class="elsevierStyleCrossRefs" href="#bib1155"><span class="elsevierStyleSup">79,82</span></a> found the risk to be 3 times higher in patients on dialysis (twice as high in transplant patients) compared to healthy subjects.<a class="elsevierStyleCrossRef" href="#bib1155"><span class="elsevierStyleSup">79</span></a> These figures are lower than those reported in previous studies.<a class="elsevierStyleCrossRefs" href="#bib1085"><span class="elsevierStyleSup">65–68,83</span></a> It is important to note that all these fractures occur at a younger age (approximately 10 years younger) and are associated with a significant increase in morbidity and mortality.<a class="elsevierStyleCrossRef" href="#bib1080"><span class="elsevierStyleSup">64</span></a> For example, mortality (unadjusted) is 3.7 times higher and the death/rehospitalisation rate is 4 times higher in patients on dialysis with fractures compared with patients with no fractures.<a class="elsevierStyleCrossRefs" href="#bib0970"><span class="elsevierStyleSup">42,63,64,77,78,84</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Vertebral fractures</span> are the most common outcome of OP, and are also a major risk factor for other fractures and morbidity and mortality.<a class="elsevierStyleCrossRefs" href="#bib0775"><span class="elsevierStyleSup">3,56,82,85,86</span></a> They are frequently misdiagnosed as acute lower back pain, while in other cases they can be silent, insidious and progressive, and are only diagnosed fortuitously by the foreshortening of the vertebral body (<span class="elsevierStyleItalic">morphometric</span> vertebral fracture) (<a class="elsevierStyleCrossRef" href="#fig0025">Fig. 5</a>). More than 2/3 of vertebral fractures remain undiagnosed in the general population<a class="elsevierStyleCrossRef" href="#bib1190"><span class="elsevierStyleSup">86</span></a> and are found in more than 25% of patients undergoing pre-transplant workup.<a class="elsevierStyleCrossRef" href="#bib1195"><span class="elsevierStyleSup">87</span></a> In addition, the combined use of BMD and detection of vertebral fractures appears to improve the assessment of vital risk. For example, Genant's classification (<a class="elsevierStyleCrossRef" href="#fig0025">Fig. 5</a>),<a class="elsevierStyleCrossRef" href="#bib1185"><span class="elsevierStyleSup">85</span></a> though rarely used by nephrologists,<a class="elsevierStyleCrossRefs" href="#bib1200"><span class="elsevierStyleSup">88,89</span></a> has proven useful in the general population, and seems to have prognostic utility in patients with CKD<a class="elsevierStyleCrossRef" href="#bib1205"><span class="elsevierStyleSup">89</span></a> or on dialysis.<a class="elsevierStyleCrossRef" href="#bib1200"><span class="elsevierStyleSup">88</span></a> Currently, vertebral morphometry (“Vertebral Fracture Assessment” or “Lateral Vertebral Acquisition”) can be performed on lateral dorsal-lumbar column images using a densitometer<a class="elsevierStyleCrossRef" href="#bib1210"><span class="elsevierStyleSup">90</span></a>; the technique has also been used in patients with CKD.<a class="elsevierStyleCrossRef" href="#bib1215"><span class="elsevierStyleSup">91</span></a> Finally, it is important to note that the risk of vertebral fracture does not appear to be clearly higher in patients with CKD<a class="elsevierStyleCrossRef" href="#bib1040"><span class="elsevierStyleSup">56</span></a> or in those at different stages of pre-dialysis CKD.<a class="elsevierStyleCrossRef" href="#bib1220"><span class="elsevierStyleSup">92</span></a> This may be due to the different mechanical properties of bone elasticity and the forces applied (vertical or parallel) to different types of bone (cortical vs. trabecular) in these patients.<a class="elsevierStyleCrossRef" href="#bib0845"><span class="elsevierStyleSup">17</span></a> Rodríguez-García et al., in a Spanish population of 193 patients on dialysis, found the prevalence of vertebral fractures to be 26.5% vs. 24.1% in the general population.<a class="elsevierStyleCrossRef" href="#bib1040"><span class="elsevierStyleSup">56</span></a> The risk of <span class="elsevierStyleItalic">hip</span> fracture in CKD, however, is clearly higher than in the general population,<a class="elsevierStyleCrossRef" href="#bib0845"><span class="elsevierStyleSup">17</span></a> being 3- to 4-fold higher in dialysis patients vs. the general population and patients without dialysis.<a class="elsevierStyleCrossRefs" href="#bib1150"><span class="elsevierStyleSup">78,79</span></a> This, of course, is the most serious consequence of OP, since it is associated with an increased risk of new fractures and premature death, and underscores the importance of performing interventions to reduce this risk.<a class="elsevierStyleCrossRefs" href="#bib0830"><span class="elsevierStyleSup">14,56,64,90,93</span></a></p><elsevierMultimedia ident="fig0025"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Bone mineral density, risk of fracture and chronic kidney disease</span><p id="par0060" class="elsevierStylePara elsevierViewall">In routine clinical practice, diagnosis of OP is based on the measurement of BMD by DEXA.<a class="elsevierStyleCrossRefs" href="#bib0770"><span class="elsevierStyleSup">2,14,94</span></a> Though still the “gold standard”, the accuracy of this scanning technique varies greatly, and does not take bone quality into account.<a class="elsevierStyleCrossRef" href="#bib1235"><span class="elsevierStyleSup">95</span></a> Despite the differential characteristics of bone fragility in patients with CKD, measurement of BMD should probably follow the same indications as for the general population, especially in patients with intermediate or high risk of fractures (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>, <a class="elsevierStyleCrossRefs" href="#fig0010">Figs. 2–4</a>).<a class="elsevierStyleCrossRef" href="#bib0895"><span class="elsevierStyleSup">27</span></a> Obviously, as mentioned in current guidelines, BMD should be performed only when its result can impact therapeutic decisions.<a class="elsevierStyleCrossRef" href="#bib1240"><span class="elsevierStyleSup">96</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">The measurement of BMD by DEXA, or less frequently by computed tomography (CT), is also a useful tool for the evaluation of bone fragility in patients with CKD.<a class="elsevierStyleCrossRefs" href="#bib0895"><span class="elsevierStyleSup">27,97</span></a> However, the relationship between bone fracture and BMD in these patients is more complex. Thus, certain anatomical and histological features must be taken into account when interpreting the results in patients with CKD, since <span class="elsevierStyleItalic">cortical</span> bone involvement is more prevalent in these patients.<a class="elsevierStyleCrossRefs" href="#bib1230"><span class="elsevierStyleSup">94,98</span></a> DEXA cannot distinguish between these features, and relies on location to indicate more cortical (radius, femur) or trabecular (lumbar) involvement. Furthermore, DEXA can overestimate BMD in the spine, particularly in patients with CKD, due to the increase in aortic calcifications and the high prevalence of lumbar osteoarthritis.<a class="elsevierStyleCrossRefs" href="#bib0830"><span class="elsevierStyleSup">14,27</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">It is very important to consider that the different forms of ROD can show a <span class="elsevierStyleItalic">similar decrease in BMD</span> in CKD patients.<a class="elsevierStyleCrossRef" href="#bib0800"><span class="elsevierStyleSup">8</span></a> Therefore, using DEXA, patients with high-turnover or low-turnover ROD can show the same densitometric measurements as a classic “senile” OP profile (<a class="elsevierStyleCrossRef" href="#fig0030">Fig. 6</a>). This is why the 2009 KDIGO guidelines<a class="elsevierStyleCrossRef" href="#bib0825"><span class="elsevierStyleSup">13</span></a> established that “in patients with CKD stages 3–5D with evidence of CKD–MBD, we suggest that BMD testing <span class="elsevierStyleItalic">not</span> be performed routinely, because BMD <span class="elsevierStyleItalic">does not</span> predict fracture risk as it does in the general population, and BMD <span class="elsevierStyleItalic">does not</span> predict the type of ROD”.<a class="elsevierStyleCrossRef" href="#bib0825"><span class="elsevierStyleSup">13</span></a> In fact, this suggestion was based on the assumption that loss of BMD could essentially be due to the calcium-phosphorous metabolism abnormalities associated with CKD (e.g. hyperparathyroidism), and that controlling phosphorus and parathyroid hormone levels was considered to be safer and more appropriate for the control of ROD than antiresorptive therapy, especially in patients with eGFR<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>30<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span>.<a class="elsevierStyleCrossRefs" href="#bib0825"><span class="elsevierStyleSup">13,96</span></a> On the other hand, a diagnosis of “OP” in an individual, without considering the possible coexistence of CKD, would require a different clinical approach involving the use of antiresorptive agents that could lead to the onset or worsening of ABD.<a class="elsevierStyleCrossRefs" href="#bib0825"><span class="elsevierStyleSup">13,99</span></a></p><elsevierMultimedia ident="fig0030"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">However, previous observations showing that decreased BMD is more common in patients with CKD stages 3–4 have now been confirmed, and, as mentioned above, several longitudinal studies have also confirmed the existence of an independent relationship between changes in renal function and <span class="elsevierStyleItalic">accelerated</span> loss of BMD with age.<a class="elsevierStyleCrossRefs" href="#bib0935"><span class="elsevierStyleSup">35,73–76</span></a> Furthermore, there has been no solid evidence of the relationship between BMD and risk of fracture in patients on dialysis, with studies showing various associations or no association at all.<a class="elsevierStyleCrossRef" href="#bib0895"><span class="elsevierStyleSup">27</span></a> However, a recent meta-analysis and systematic review of 13 published studies on the potential association between DEXA and fractures in patients with CKD (pre-dialysis and dialysis)<a class="elsevierStyleCrossRef" href="#bib1260"><span class="elsevierStyleSup">100</span></a> showed that BMD was significantly lower in the femoral neck, lumbar spine, distal third of radius and ultradistal radius in patients with fractures, irrespective of dialysis. Although this meta-analysis has obvious limitations, it did suggest that BMD is able to predict the risk of fracture in patients with CKD,<a class="elsevierStyleCrossRef" href="#bib1260"><span class="elsevierStyleSup">100</span></a> while in patients with hyperparathyroidism, the distal 1/3 of the radius could be more representative of changes in cortical bone, as recommended in the 2015 International Society for Clinical Densitometry guidelines.<a class="elsevierStyleCrossRef" href="#bib1265"><span class="elsevierStyleSup">101</span></a> Several studies show that this location is predictive of the risk of fracture in patients with CKD 3–5D,<a class="elsevierStyleCrossRefs" href="#bib1265"><span class="elsevierStyleSup">101–103</span></a> but should not be measured in the arm carrying the AV fistula.<a class="elsevierStyleCrossRef" href="#bib1280"><span class="elsevierStyleSup">104</span></a> In addition, at least 5 prospective cohort studies evaluating DEXA and incidence of fractures in adults with CKD stages 3a–5D have confirmed the good predictive capacity of BMD in patients with CKD.<a class="elsevierStyleCrossRefs" href="#bib0970"><span class="elsevierStyleSup">42,102,105–107</span></a></p><p id="par0080" class="elsevierStylePara elsevierViewall">The first such study was performed in 485 Japanese patients on haemodialysis, and showed that baseline BMD (femoral neck and total hip) was independently associated with an increase in the incidence of any type of fracture (HR 0.65 [95% CI<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.47–0.90]).<a class="elsevierStyleCrossRef" href="#bib1285"><span class="elsevierStyleSup">105</span></a> Other authors<a class="elsevierStyleCrossRef" href="#bib1270"><span class="elsevierStyleSup">102</span></a> have shown that BMD measured by DEXA (total hip, lumbar spine, ultra-distal and distal third of radius) and high-resolution peripheral quantitative CT scan (HR-pQCT) of the radius could predict fractures in pre-dialysis adults with stage 3–5 CKD.<a class="elsevierStyleCrossRef" href="#bib1270"><span class="elsevierStyleSup">102</span></a> Yencheck et al., meanwhile, evaluated the association between BMD by DEXA and fractures in a prospective study in 2,754 non-institutionalised older individuals (mean age 73.6 years),<a class="elsevierStyleCrossRef" href="#bib1290"><span class="elsevierStyleSup">106</span></a> confirming the association between decreased BMD in the femoral neck and a higher risk of fracture, with or without CKD.<a class="elsevierStyleCrossRef" href="#bib1290"><span class="elsevierStyleSup">106</span></a> Finally, in a recent study of 1,426 individuals aged ≥40 (mean 67 years), Naylor et al.,<a class="elsevierStyleCrossRef" href="#bib1295"><span class="elsevierStyleSup">107</span></a> showed that, irrespective of BMD, individuals with CKD and a trabecular bone score (TBS) from lumbar spine DEXA <span class="elsevierStyleItalic">below</span> the median (<1.277) were 3 times more likely to suffer a fracture at 5 years. TBS is a texture analysis obtained by DEXA imaging that correlates with bone microarchitecture.<a class="elsevierStyleCrossRefs" href="#bib1300"><span class="elsevierStyleSup">108,109</span></a> The authors also showed that the association between TBS and fracture was independent of BMD and other risk factors. However, this sample included a limited number of CKD patients (especially advanced stage), so further validation is needed.<a class="elsevierStyleCrossRefs" href="#bib0880"><span class="elsevierStyleSup">24,31</span></a> Similar findings have been described in transplant patients.<a class="elsevierStyleCrossRef" href="#bib1310"><span class="elsevierStyleSup">110</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">As mentioned above, quantitative CT can distinguish between cortical and trabecular bone. Studies using quantitative CT, for example, have found that lumbar <span class="elsevierStyleItalic">cortical</span> BMD is the best predictor of vertebral fractures in dialysis patients.<a class="elsevierStyleCrossRef" href="#bib1315"><span class="elsevierStyleSup">111</span></a> Quantitative CT identified prospectively more bone loss at the hip than DEXA.<a class="elsevierStyleCrossRef" href="#bib1245"><span class="elsevierStyleSup">97</span></a> There is also evidence that reduction of cortical BMD in the radius measured by CT increased the risk of fracture 16 fold<a class="elsevierStyleCrossRef" href="#bib0935"><span class="elsevierStyleSup">35</span></a> and, more recently, that HR-pQCT allowed visualisation of ultrastructural details that could improve its predictive value.<a class="elsevierStyleCrossRefs" href="#bib0915"><span class="elsevierStyleSup">31,63,112–114</span></a> However, this scanning technique was not superior to DEXA in other cohorts.<a class="elsevierStyleCrossRef" href="#bib1270"><span class="elsevierStyleSup">102</span></a> HR-pQCT does not, of course, provide the information on bone turnover and mineralisation that can be obtained from bone biopsy, and it is expensive and not widely available.<a class="elsevierStyleCrossRef" href="#bib1075"><span class="elsevierStyleSup">63</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">Other tests that are more portable and therefore used for mass screening are peripheral DEXA (forearm, finger or heel) and quantitative ultrasound (QUS) bone densitometry, usually in the calcaneus. Their results are more limited and not equivalent to DEXA; moreover, these techniques are less precise and accurate, and abnormal results should be confirmed with central DEXA.<a class="elsevierStyleCrossRef" href="#bib0925"><span class="elsevierStyleSup">33</span></a> Other non-invasive techniques, such as magnetic resonance and different spectroscopic methods, have also been used in a research context to evaluate bone quality.<a class="elsevierStyleCrossRef" href="#bib1075"><span class="elsevierStyleSup">63</span></a> One of the most interesting techniques is bone microindentation, which involves delivering a microscopic impact that directly measures the mechanical strength of bone.<a class="elsevierStyleCrossRefs" href="#bib1335"><span class="elsevierStyleSup">115–118</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Biochemical parameters and risk of fracture</span><p id="par0095" class="elsevierStylePara elsevierViewall">A detailed review of the utility of bone remodelling biomarkers in the diagnosis and therapeutic management of ROD and/or patients with OP is beyond the scope of this review, so we refer the reader to the general guidelines and other recently published reviews.<a class="elsevierStyleCrossRefs" href="#bib0800"><span class="elsevierStyleSup">8,13,27,96,119</span></a> Nevertheless, it is important to bear in mind that in the absence of bone biopsy, and despite various controversies, intact PTH and/or bone alkaline phosphatase levels are the best (albeit suboptimal) surrogate biomarkers for CKD histology studies.<a class="elsevierStyleCrossRef" href="#bib1320"><span class="elsevierStyleSup">112</span></a> Intact PTH (inverted U- or J-shaped curve) and alkaline phosphatase (linear relationship) are also predictors of survival in these patients.<a class="elsevierStyleCrossRefs" href="#bib1360"><span class="elsevierStyleSup">120,121</span></a> The <span class="elsevierStyleItalic">lowest</span> mortality risk is observed in patients on dialysis who have PTH values between 150 and 300<span class="elsevierStyleHsp" style=""></span>pg/ml (2× to 5× the upper limit of normal),<a class="elsevierStyleCrossRefs" href="#bib1360"><span class="elsevierStyleSup">120,122,123</span></a> or approximately 400<span class="elsevierStyleHsp" style=""></span>pg/ml, according to a recent study.<a class="elsevierStyleCrossRef" href="#bib1380"><span class="elsevierStyleSup">124</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">There is some consensus that the sensitivity and specificity of PTH levels in patients on dialysis is greater in the <span class="elsevierStyleItalic">low</span> range, where it is associated with ABD (i.e. PTH levels less than 2× the lower limit of normal),<a class="elsevierStyleCrossRef" href="#bib0840"><span class="elsevierStyleSup">16</span></a> or in the <span class="elsevierStyleItalic">very high</span> range (9× the upper limit of normal), where it is associated with osteitis fibrosa secondary to hyperparathyroidism. Both low and high levels of PTH have been associated with a decrease in BMD and a high incidence of fractures.<a class="elsevierStyleCrossRefs" href="#bib1145"><span class="elsevierStyleSup">77,83,125–127</span></a> For instance, Atsumi et al. reported that Japanese patients with PTH in the <span class="elsevierStyleItalic">lower</span> tertile had a 2.4-fold higher risk of <span class="elsevierStyleItalic">vertebral</span> fracture than those in the medium tertile, and a 1.6-fold higher risk than those in the top tertile.<a class="elsevierStyleCrossRef" href="#bib1395"><span class="elsevierStyleSup">127</span></a> In the DOPPS study, in contrast, levels >900<span class="elsevierStyleHsp" style=""></span>pg/ml were associated with the highest prevalence of fractures.<a class="elsevierStyleCrossRef" href="#bib1400"><span class="elsevierStyleSup">128</span></a> Differences in the strength of association between BMD-risk of fracture and other parameters is evidenced by the results of another study, in which the risk was <span class="elsevierStyleItalic">less</span> severe in patients with PTH >65<span class="elsevierStyleHsp" style=""></span>pg/ml than in those with PTH <65<span class="elsevierStyleHsp" style=""></span>pg/ml.<a class="elsevierStyleCrossRef" href="#bib1290"><span class="elsevierStyleSup">106</span></a> In addition, in another sample of Japanese patients on haemodialysis, it was observed that PTH levels both lower and higher than the standard 150–300<span class="elsevierStyleHsp" style=""></span>pg/ml were associated with incident fractures (HR 3.47 and 5.88, respectively).<a class="elsevierStyleCrossRef" href="#bib1285"><span class="elsevierStyleSup">105</span></a> In the same study, elevated bone alkaline phosphatase was also associated with incident fractures.</p><p id="par0105" class="elsevierStylePara elsevierViewall">On the other hand, there are no clear data to suggest that biomarkers (such as moderate increases in PTH) are associated with loss of bone strength or increased incidence of fractures in patients with stage 1–3 and possibly stage 4 CKD. Therefore, in the absence of clear, persistent metabolic abnormalities, the first cause of fracture in these patients could be “classic” OP,<a class="elsevierStyleCrossRef" href="#bib1230"><span class="elsevierStyleSup">94</span></a> for which new therapeutic interventions are available.<a class="elsevierStyleCrossRefs" href="#bib0880"><span class="elsevierStyleSup">24,63,96</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">There is little information about plasma vitamin D levels (calcidiol [25OH-vitamin D]), bone histology, and risk of fracture in patients with CKD.<a class="elsevierStyleCrossRef" href="#bib1395"><span class="elsevierStyleSup">127</span></a> Low levels of calcidiol (<20<span class="elsevierStyleHsp" style=""></span>ng/ml) have been correlated with bone turnover, the rate of osteoid synthesis and mineralisation, and static histomorphometric parameters in dialysis patients.<a class="elsevierStyleCrossRef" href="#bib1405"><span class="elsevierStyleSup">129</span></a> In other populations with CKD, both receiving and not receiving dialysis, evidence of a correlation between levels of vitamin D and lumbar or radial BMD has been reported<a class="elsevierStyleCrossRefs" href="#bib0960"><span class="elsevierStyleSup">40,130–133</span></a>; however, other studies found no such association.<a class="elsevierStyleCrossRef" href="#bib1430"><span class="elsevierStyleSup">134</span></a> In the study by Ambrus et al., both decreased levels of calcidiol and low levels of PTH, among others, were independent predictors of fracture risk.<a class="elsevierStyleCrossRef" href="#bib1420"><span class="elsevierStyleSup">132</span></a> For all these reasons, determination of calcidiol levels could guide replacement therapy in these patients.<a class="elsevierStyleCrossRefs" href="#bib0850"><span class="elsevierStyleSup">18,135,136</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">Other biomarkers (propeptides, telopeptides, etc.) are, generally speaking, of little use in patients with CKD and/or do not correlate with predicted bone loss or response to treatment,<a class="elsevierStyleCrossRef" href="#bib0805"><span class="elsevierStyleSup">9</span></a> and their use has scant benefit in daily clinical practice.<a class="elsevierStyleCrossRef" href="#bib0895"><span class="elsevierStyleSup">27</span></a> Most biomarkers are excreted in urine,<a class="elsevierStyleCrossRef" href="#bib1230"><span class="elsevierStyleSup">94</span></a> and can therefore be elevated in CKD independently, while others are significantly influenced by haemodialysis.<a class="elsevierStyleCrossRef" href="#bib1445"><span class="elsevierStyleSup">137</span></a> Some recent publications, pending confirmation, show a potential predictive utility for some new markers, such as FGF-23 or sclerostin.<a class="elsevierStyleCrossRefs" href="#bib1245"><span class="elsevierStyleSup">97,138–141</span></a> FGF23 could be a marker of bone mineralisation (inversely related to osteoid accumulation)<a class="elsevierStyleCrossRef" href="#bib1470"><span class="elsevierStyleSup">142</span></a> by regulating non-tissue-specific alkaline phosphatase, independently of Klotho, through the FGFR3 receptor,<a class="elsevierStyleCrossRef" href="#bib1460"><span class="elsevierStyleSup">140</span></a> and elevated levels of FGF23 found in CKD (negatively associated with BMD)<a class="elsevierStyleCrossRef" href="#bib1475"><span class="elsevierStyleSup">143</span></a> could contribute to bone loss by stimulating Dkk1 through a Klotho-mediated process.<a class="elsevierStyleCrossRef" href="#bib1480"><span class="elsevierStyleSup">144</span></a> Aside from this, it is clear that all these biomarkers are still of little use in the context of CKD and/or OP.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Bone biopsy</span><p id="par0120" class="elsevierStylePara elsevierViewall">Double tetracycline labelling is still the “gold standard” method of evaluating bone turnover and other dimensions of ROD,<a class="elsevierStyleCrossRefs" href="#bib1320"><span class="elsevierStyleSup">112,145,146</span></a> although it is rarely used due to the logistical difficulties involved. However, there is no evidence to date of a correlation between fractures, type of ROD or histomorphometric variables,<a class="elsevierStyleCrossRefs" href="#bib0895"><span class="elsevierStyleSup">27,63</span></a> and prospective studies to compare DEXA, HR-pQCT and histomorphometry are needed.<a class="elsevierStyleCrossRef" href="#bib1075"><span class="elsevierStyleSup">63</span></a> New perspectives on the evaluation of <span class="elsevierStyleItalic">cortical</span> bone and immunohistochemical techniques could revalidate the need for bone biopsies in nephrology and rheumatology,<a class="elsevierStyleCrossRef" href="#bib1485"><span class="elsevierStyleSup">145</span></a> and could help distinguish between OP and “classic” forms of ROD (especially ABD). For example, recent studies have reported that femoral BMD is associated with cortical porosity,<a class="elsevierStyleCrossRef" href="#bib1490"><span class="elsevierStyleSup">146</span></a> and a higher stage of kidney disease is associated with thinner cortices, which could contribute to higher risk of fracture in this population.<a class="elsevierStyleCrossRef" href="#bib1495"><span class="elsevierStyleSup">147</span></a> Although there is no irrefutable evidence that antiresorptive agents cause ABD,<a class="elsevierStyleCrossRef" href="#bib1240"><span class="elsevierStyleSup">96</span></a> or that their administration in a patient with ABD can affect bone strength, until the publication of the new guidelines,<a class="elsevierStyleCrossRef" href="#bib1240"><span class="elsevierStyleSup">96</span></a> it seemed reasonable to exclude ABD before starting this therapy, particularly in patients with eGFR <30<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span>.<a class="elsevierStyleCrossRefs" href="#bib0825"><span class="elsevierStyleSup">13,14,94</span></a></p><p id="par0125" class="elsevierStylePara elsevierViewall">In contrast, some authors have ventured to suggest that the introduction of the concept of “uraemic OP” challenges the consensus of bone biopsy as the gold standard diagnostic technique and heralds a paradigm shift.<a class="elsevierStyleCrossRefs" href="#bib0845"><span class="elsevierStyleSup">17,24</span></a> Those in favour of this change argue that bone formation and mineralization rates may not be the most determinant factors of fracture propensity, because the relationship between these factors and bone chemical properties remains unknown.<a class="elsevierStyleCrossRef" href="#bib0845"><span class="elsevierStyleSup">17</span></a> We have already mentioned that it is unclear whether changes in mineral metabolism are major determinants of fracture risk in patients with CKD,<a class="elsevierStyleCrossRef" href="#bib1170"><span class="elsevierStyleSup">82</span></a> that the role of PTH levels (at both ends of the scale) is controversial or marginal, and that no correlation has yet been observed between calcium and phosphorus levels and risk of fracture.<a class="elsevierStyleCrossRefs" href="#bib1175"><span class="elsevierStyleSup">83,125</span></a> These data suggest that strategies to prevent fractures in patients with CKD must take into account other factors that are also found in the general population and are not solely related to the traditional aims of our intervention.<a class="elsevierStyleCrossRefs" href="#bib0775"><span class="elsevierStyleSup">3,24,82</span></a> From a practical point of view, on the other hand, the 2009 KDIGO guidelines recommended performing a bone biopsy before starting antiresorptive treatment in patients with eGFR <30<span class="elsevierStyleHsp" style=""></span>ml/min/1.73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span>, but the logistical difficulties involved (performance of the biopsy and external diagnosis) could prevent patients with CKD from receiving the treatment they need.<a class="elsevierStyleCrossRef" href="#bib0880"><span class="elsevierStyleSup">24</span></a> These factors and their therapeutic repercussions will be discussed in the second part of this review.<a class="elsevierStyleCrossRef" href="#bib0850"><span class="elsevierStyleSup">18</span></a></p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Conclusion</span><p id="par0130" class="elsevierStylePara elsevierViewall">Patients with CKD have a higher risk of bone fractures than the general population, with non-vertebral fractures being even more common than vertebral fractures. Given the association between fractures and increased morbidity and mortality, we believe that nephrologists should evaluate other risk factors, and should quantify the risk of fracture (especially in patients with mild-moderate CKD) using methods and tools similar to those used in the general population (i.e. FRAX<span class="elsevierStyleSup">®</span>, BMD). In fact, the predictive capacity of these techniques, even in the presence of CKD, has been demonstrated in several studies. For this reason, the new KDIGO 2017 guidelines suggest using BMD to assess the risk of fracture in patients with CKD 3a–5D with evidence of CKD–MBD and/or <span class="elsevierStyleItalic">OP risk factors</span> if the results can impact therapeutic decisions (evidence 2B).<a class="elsevierStyleCrossRef" href="#bib1240"><span class="elsevierStyleSup">96</span></a> This could involve additional interventions to reduce falls, and the administration of drugs to treat OP in the case of low or progressively decreasing BMD. Therefore, we believe that at least in selected groups of patients with factors associated with increased risk of fracture, with no severe biochemical changes and/or serial determinations (i.e. 2-yearly) that show frank bone loss,<a class="elsevierStyleCrossRef" href="#bib1265"><span class="elsevierStyleSup">101</span></a> treatment of OP should be considered individually and therapeutic nihilism should be avoided. The availability of bone biopsy should not always be a limiting factor.<a class="elsevierStyleCrossRefs" href="#bib0880"><span class="elsevierStyleSup">24,96</span></a> Finally, we encourage nephrologists to pay close attention to the latest information in this relatively new area, and call on researchers to conduct prospective studies that do not systematically exclude patients with CKD.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Key concepts</span><p id="par0135" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">•</span><p id="par0140" class="elsevierStylePara elsevierViewall">OP and CKD independently influence bone and cardiovascular health.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">•</span><p id="par0145" class="elsevierStylePara elsevierViewall">Patients with CKD may also present “classic” OP, such as that associated with age and/or gender.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">•</span><p id="par0150" class="elsevierStylePara elsevierViewall">A significant number of patients with CKD present significant loss of BMD.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">•</span><p id="par0155" class="elsevierStylePara elsevierViewall">Loss of BMD determines not only a high risk of fracture but also a significant increase in associated morbidity and mortality.</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">•</span><p id="par0160" class="elsevierStylePara elsevierViewall">There is evidence that loss of BMD is also predictive of fracture risk in patients with CKD, although it could underestimate the risk of fracture, particularly in stages 4–5D.</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">•</span><p id="par0165" class="elsevierStylePara elsevierViewall">BMD alone does not distinguish between its underlying causes (hyperparathyroidism, adynamic bone disease and/or senile osteoporosis, etc.).</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">•</span><p id="par0170" class="elsevierStylePara elsevierViewall">In patients with CKD (especially mild-moderate), risk factors for fracture should be assessed and quantified if possible (i.e. with FRAX<span class="elsevierStyleSup">®</span>) in a similar way to the general population.</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">•</span><p id="par0175" class="elsevierStylePara elsevierViewall">The 2017 KDIGO guidelines suggest using BMD to assess the risk of fracture in patients with CKD with evidence of CKD–MBD and/or OP risk factors, if the results can impact therapeutic decisions.</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">•</span><p id="par0180" class="elsevierStylePara elsevierViewall">The possibility of treating OP, with or without a prior bone biopsy, should at least be considered in selected groups of patients and individually (i.e. with factors associated with a high risk of fracture and in the absence of severe, persistent biochemical alterations).</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">•</span><p id="par0185" class="elsevierStylePara elsevierViewall">New guidelines steer clinicians away from therapeutic nihilism due to the recognised importance of fractures and their complications in CKD.</p></li></ul></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Conflicts of interest</span><p id="par0190" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres1106886" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1046344" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1106887" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1046343" "titulo" => "Palabras clave" ] 4 => array:3 [ "identificador" => "sec0005" "titulo" => "Introduction" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0010" "titulo" => "General concepts of osteoporosis, risk factors and clinical consequences" ] 1 => array:2 [ "identificador" => "sec0015" "titulo" => "Epidemiology of fractures in chronic kidney disease" ] 2 => array:2 [ "identificador" => "sec0020" "titulo" => "Bone mineral density, risk of fracture and chronic kidney disease" ] 3 => array:2 [ "identificador" => "sec0025" "titulo" => "Biochemical parameters and risk of fracture" ] 4 => array:2 [ "identificador" => "sec0030" "titulo" => "Bone biopsy" ] ] ] 5 => array:2 [ "identificador" => "sec0035" "titulo" => "Conclusion" ] 6 => array:2 [ "identificador" => "sec0040" "titulo" => "Key concepts" ] 7 => array:2 [ "identificador" => "sec0045" "titulo" => "Conflicts of interest" ] 8 => array:2 [ "identificador" => "xack375806" "titulo" => "Acknowledgements" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2017-09-20" "fechaAceptado" => "2017-12-31" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1046344" "palabras" => array:7 [ 0 => "Osteoporosis" 1 => "CKD–MBD" 2 => "Bone mineral density" 3 => "Fractures" 4 => "FRAX" 5 => "Chronic kidney disease" 6 => "DEXA" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1046343" "palabras" => array:7 [ 0 => "Osteoporosis" 1 => "CKD-MBD" 2 => "Densidad mineral ósea" 3 => "Fracturas" 4 => "FRAX" 5 => "Enfermedad renal crónica" 6 => "DEXA" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Osteoporosis (OP) and chronic kidney disease (CKD) independently influence bone and cardiovascular health. A considerable number of patients with CKD, especially those with stages 3a to 5D, have a significantly reduced bone mineral density leading to a high risk of fracture and a significant increase in associated morbidity and mortality. Independently of classic OP related to age and/or gender, the mechanical properties of bone are also affected by inherent risk factors for CKD (“uraemic OP”). In the first part of this review, we will analyse the general concepts regarding bone mineral density, OP and fractures, which have been largely undervalued until now by nephrologists due to the lack of evidence and diagnostic difficulties in the context of CKD. It has now been proven that a reduced bone mineral density is highly predictive of fracture risk in CKD patients, although it does not allow a distinction to be made between the causes which generate it (hyperparathyroidism, adynamic bone disease and/or senile osteoporosis, etc.). Therefore, in the second part, we will analyse the therapeutic indications in different CKD stages. In any case, the individual assessment of factors which represent a higher or lower risk of fracture, the quantification of this risk (i.e. using tools such as FRAX<span class="elsevierStyleSup">®</span>) and the potential indications for densitometry in patients with CKD could represent an important first step pending new clinical guidelines based on randomised studies which do not exclude CKD patients, all the while avoiding therapeutic nihilism in an area of growing importance.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Osteoporosis (OP) y enfermedad renal crónica (ERC) influyen de manera independiente en la salud ósea y cardiovascular. Un número significativo de pacientes con ERC, especialmente desde estadios 3a a 5D, presentan una disminución significativa de la densidad mineral ósea condicionando un alto riesgo de fractura y un incremento importante de la morbimortalidad asociada. Independientemente de la OP clásica asociada a edad y/o sexo, las propiedades mecánicas del hueso se encuentran afectadas adicionalmente por factores intrínsecos a la ERC («OP urémica»). En la primera parte de esta revisión, analizaremos conceptos generales sobre densidad mineral ósea, OP y fracturas, en gran parte infravalorados hasta ahora por los nefrólogos debido a la falta de evidencias y a las dificultades diagnósticas en el contexto de la ERC. Actualmente se ha demostrado que una densidad mineral ósea disminuida es realmente predictiva del riesgo de fracturas en pacientes con ERC, aunque no permite distinguir entre las causas que la originan (hiperparatiroidismo, enfermedad adinámica del hueso y/o osteoporosis senil, etc.). Por ello, en la segunda parte analizaremos las implicaciones terapéuticas en distintos estadios de la ERC. En cualquier caso, la valoración individualizada de los factores mayores y menores del riesgo de fractura, la cuantificación de dicho riesgo (i.e. con el uso de herramientas como el FRAX<span class="elsevierStyleSup">®</span>) y las indicaciones potenciales de densitometría en pacientes con ERC podrían constituir un primer paso importante en espera de nuevas guías clínicas basadas en estudios aleatorizados que no excluyan a pacientes con ERC, evitando mientras tanto nihilismo terapéutico en un área de creciente importancia.</p></span>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Bover J, Ureña-Torres P, Torregrosa J-V, Rodríguez-García M, Castro-Alonso C, Górriz JL, et al. Osteoporosis, densidad mineral ósea y complejo CKD-MBD (I): consideraciones diagnósticas. Nefrologia. 2018;38:476–490.</p>" ] ] "multimedia" => array:7 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "Adapted from Moe<a class="elsevierStyleCrossRef" href="#bib1515"><span class="elsevierStyleSup">151</span></a> and West et al.<a class="elsevierStyleCrossRef" href="#bib1230"><span class="elsevierStyleSup">94</span></a>" "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1181 "Ancho" => 2494 "Tamanyo" => 197425 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Relationship between Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD), renal osteodystrophy (bone changes secondary to chronic kidney disease [CKD]) and OP (associated with uraemia or age and gender of patients, among other factors). Bone strength is determined not only by bone mineral <span class="elsevierStyleItalic">density</span>, but also by bone <span class="elsevierStyleItalic">quality</span>, expressed by its determinants.<a class="elsevierStyleCrossRefs" href="#bib1230"><span class="elsevierStyleSup">94,151</span></a> Although some authors use the term “uraemic” OP,<a class="elsevierStyleCrossRef" href="#bib0845"><span class="elsevierStyleSup">17</span></a> it is important to remember the existence of non-terminal CKD, which could be integrated within the CKD–MBD complex due to its capacity to worsen the condition.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2036 "Ancho" => 3000 "Tamanyo" => 548355 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Example of the Fracture Risk Assessment Tool (FRAX<span class="elsevierStyleSup">®</span>): for Spain (<a class="elsevierStyleInterRef" target="_blank" id="intr0005" href="http://www.shef.ac.uk/FRAX/tool.aspx?country=4">http://www.shef.ac.uk/FRAX/tool.aspx?country=4</a>). The FRAX<span class="elsevierStyleSup">®</span> algorithm calculates the probability of a major osteoporotic fracture in a specific country. In addition to the obvious factors shown, previous or current administration of corticosteroids for more than 3 months (5<span class="elsevierStyleHsp" style=""></span>mg or more of prednisolone or equivalent), OP concomitant with rheumatoid arthritis, OP secondary to disorders closely linked to it (type 1 diabetes, adult osteogenesis imperfecta, chronic untreated hyperthyroidism, hypogonadism or premature menopause, chronic malnutrition, malabsorption and chronic liver disease), ingestion of more than three units of alcohol per day, and finally, optionally, BMD at the neck of the femur are all taken into consideration. When entering BMD values in the table, the trabecular bone score, if available, can also be entered later. The shortcomings of FRAX<span class="elsevierStyleSup">®</span> include the use of dichotomous variables (yes/no), and the absence of certain variables, such as the number of previous fractures, the corticosteroid dose and the number of falls suffered. In addition, it does not differentiate between vertebral and non-vertebral fractures, the evaluation of secondary OP is incomplete (kidney disease or glomerular filtration is not taken into account, among other causes), and concerns have been raised about the representativeness of the Spanish cohort.<a class="elsevierStyleCrossRefs" href="#bib0990"><span class="elsevierStyleSup">46,47,115</span></a> In centres where DEXA is not available for BMD measurement, FRAX<span class="elsevierStyleSup">®</span> may be particularly useful in selecting patients for referral for DEXA.</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1273 "Ancho" => 3161 "Tamanyo" => 182609 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Estimation of fracture probability using FRAX<span class="elsevierStyleSup">®</span> (fracture probability according to risk factors [CRF]). High, intermediate, and low risk levels vary according to guidelines and countries. In the United States and the United Kingdom, ≥20% 10-year probability of major osteoporotic fracture or ≥3% probability of hip fracture is considered high, 10–20% is considered an intermediate probability (densitometry [BMD, bone mineral density] and recalculation is recommended), and <10% is considered a low probability (figures based on cost-effectiveness). Some guidelines (see <a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>) recommend recalculating FRAX (reassess probability) using BMD for both intermediate- and high-risk patients before treating (BMD can also be used to evaluate response to treatment).<a class="elsevierStyleCrossRef" href="#bib0890"><span class="elsevierStyleSup">26</span></a>.</p>" ] ] 3 => array:7 [ "identificador" => "fig0020" "etiqueta" => "Fig. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1591 "Ancho" => 1583 "Tamanyo" => 156490 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Decision tree based on the most cost-effective option in the Spanish FRIDEX cohort of Spanish women (general population) who did not receive treatment during the 10 years of follow-up.<a class="elsevierStyleCrossRef" href="#bib0995"><span class="elsevierStyleSup">47</span></a> DXA or DEXA: Dual-Energy X-ray absorptiometry; OP: osteoporosis.</p>" ] ] 4 => array:7 [ "identificador" => "fig0025" "etiqueta" => "Fig. 5" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr5.jpeg" "Alto" => 1566 "Ancho" => 2039 "Tamanyo" => 112506 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Schematic representation of Genant's semi-quantitative approach to the visual measurement of vertebral deformities. Normal<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0; mild<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1; moderate<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>2; severe<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3; doubtful<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.5. Vertebral fractures are often diagnosed fortuitously (morphometric fracture), although diagnosis can also be made on the basis of symptoms. It is based on more than 20% loss of vertebral body height in any of the vertebral segments. The following formula is used: ([posterior height of the vertebral body<span class="elsevierStyleHsp" style=""></span>−<span class="elsevierStyleHsp" style=""></span>lowest height]/posterior height)<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>100.<a class="elsevierStyleCrossRefs" href="#bib1335"><span class="elsevierStyleSup">115,152</span></a></p>" ] ] 5 => array:7 [ "identificador" => "fig0030" "etiqueta" => "Fig. 6" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr6.jpeg" "Alto" => 1401 "Ancho" => 2196 "Tamanyo" => 134841 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">The image shows how different pathologies (senile osteoporosis or osteoporosis secondary to hypogonadism, osteomalacia, adynamic bone disease and secondary hyperparathyroidism) can show the same low bone mineral density (in this example, BMD<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.750<span class="elsevierStyleHsp" style=""></span>g/cm<span class="elsevierStyleSup">2</span>) although they are caused by a completely different bone composition, and require different treatment strategies.<a class="elsevierStyleCrossRefs" href="#bib1320"><span class="elsevierStyleSup">112,133</span></a></p>" ] ] 6 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">BMD measured as <span class="elsevierStyleItalic">T-score</span> (number of standard deviations from BMD of women aged 20–29) exponentially increases the risk of fracture.<a class="elsevierStyleCrossRef" href="#bib1490"><span class="elsevierStyleSup">146</span></a> Osteopenia (<span class="elsevierStyleItalic">T</span> between −1 and −2.5): doubles the risk of fracture (2×); osteoporosis (<span class="elsevierStyleItalic">T</span><span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>−2.5): 4×; established osteoporosis (<span class="elsevierStyleItalic">T</span><span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>−2.5 and fracture); severe osteoporosis (<span class="elsevierStyleItalic">T</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>−3.5). The <span class="elsevierStyleItalic">Z</span> index (i.e. ≤−2) should be used for diagnostic purposes in the assessment of BMD in <span class="elsevierStyleItalic">pre</span>-menopausal women and men under 50 years of age.<a class="elsevierStyleCrossRef" href="#bib1265"><span class="elsevierStyleSup">101</span></a> The <span class="elsevierStyleItalic">Z</span> value indicates the relationship with the “expected” value for the patient's age. In the absence of BMD measurement, this could be indicated by the presence of a major risk factor (other than age) or 2 minor risk factors, or, according to different guidelines, 2 major or 1 major<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>2 minor. Other risk factors important for nephrologists would be (among others, and by different mechanisms): the use of loop diuretics, chronic use of heparin or anticoagulants, proton pump inhibitors, antihistamines, selective serotonin reuptake inhibitors, oestrogen and testosterone blockers, antiepileptics, aromatase inhibitors, etc.<a class="elsevierStyleCrossRefs" href="#bib1495"><span class="elsevierStyleSup">147–150</span></a> As fractures occur at a younger age in CKD, SEN 2011 Spanish guidelines suggested that, in addition to transplant patients, densitometry should be performed in women over 50 years of age and men >65 years of age with CKD (unlike the usual indication in women >65 years of age and men >70 years of age).<a class="elsevierStyleCrossRef" href="#bib1265"><span class="elsevierStyleSup">101</span></a></p><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">BMD: bone mineral density; BMI: body mass index; RR: relative risk.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " rowspan="11" align="left" valign="top">Major risk factors (RR<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>2)</td><td class="td" title="table-entry " align="left" valign="top">BMD<span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>−2.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Previous fracture (hip, spine, wrist) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>65 years \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">BMI<span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>20<span class="elsevierStyleHsp" style=""></span>kg/m<span class="elsevierStyleSup">2</span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">History of hip fracture in a first-degree relative \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Corticosteroid therapy (≥5<span class="elsevierStyleHsp" style=""></span>mg/day of prednisone or equivalent for ≥3 months) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Untreated premature ovarian failure \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Falls in the previous year (≥2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hyperparathyroidism \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Eating disorder \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Chronic malnutrition or malabsorption syndromes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " rowspan="7" align="left" valign="top">Minor risk factors</td><td class="td" title="table-entry " align="left" valign="top">Female gender \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Early menopause (40–45 years) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Current smoker \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Consumption of ≥3 units of alcohol/day \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Type 1 diabetes mellitus \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Rheumatoid arthritis \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hyperthyroidism \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1894042.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Fracture risk factors.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:152 [ 0 => array:3 [ "identificador" => "bib0765" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteoporosis: a still increasing prevalence" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0770" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteoporosis prevention, diagnosis, and therapy" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0775" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Postmenopausal osteoporosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0780" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The assessment of fracture risk" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0785" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteoporosis is a risk factor, not a disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0790" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0795" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteoporosis: chronic kidney disease in rheumatology practice" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1297-319X(15)30003-8" "Revista" => array:6 [ …6] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0800" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.)" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3265/Nefrologia.pre2011.Jan.10816" "Revista" => array:7 [ …7] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0805" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical practice guidelines for posmenopausal, glucocorticoid-induced and male osteoporosis. Spanish Society for Research on Bone and Mineral Metabolism (3rd updated version 2014)" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rce.2015.08.003" "Revista" => array:7 [ …7] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0810" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "Available at: <a class="elsevierStyleInterRef" target="_blank" id="intr0020" href="https://www.ffomc.org/sites/default/files/PAS%20FRAGILIDAD%20OSEA.pdf">https://www.ffomc.org/sites/default/files/PAS%20FRAGILIDAD%20OSEA.pdf</a> [accessed 10.04.18]" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pautas de actuación y seguimiento de la fragilidad ósea" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ …1] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0815" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:1 [ "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ …5] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0820" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/sj.ki.5000414" "Revista" => array:6 [ …6] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0825" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD–MBD)" ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0830" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteoporosis and adynamic bone in chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5301/jn.5000212" "Revista" => array:6 [ …6] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0835" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.02550508" "Revista" => array:6 [ …6] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0840" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adynamic bone disease: from bone to vessels in chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.semnephrol.2014.09.008" "Revista" => array:6 [ …6] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0845" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Uremic osteoporosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0850" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "[submitted for publication]" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteoporosis, densidad mineral ósea y complejo CKD–MBD (II): consideraciones terapéuticas" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ …3] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0855" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteoporosis, bone mineral density and CKD–MBD: treatment considerations" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s40620-017-0404-z" "Revista" => array:6 [ …6] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0860" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relationship between age, renal function and bone mineral density in the US population" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-003-1435-y" "Revista" => array:6 [ …6] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0865" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Secondary osteoporosis: pathophysiology and management" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1530/EJE-15-0118" "Revista" => array:6 [ …6] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0870" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology of osteoporosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rdc.2006.08.003" "Revista" => array:6 [ …6] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0875" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1359/jbmr.061113" "Revista" => array:6 [ …6] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0880" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fractures in patients with CKD: time for action" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.09500916" "Revista" => array:6 [ …6] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0885" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aplicación de la herramienta FRAX (R) para la determinación del riesgo de fractura en mujeres de ámbito rural" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0890" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessment of fracture risk" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-004-1780-5" "Revista" => array:6 [ …6] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0895" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of fracture risk in chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s40620-017-0398-6" "Revista" => array:6 [ …6] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0900" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European prospective osteoporosis study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0905" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A meta-analysis of previous fracture and subsequent fracture risk" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.bone.2004.03.024" "Revista" => array:6 [ …6] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0910" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Valoración del riesgo de fractura osteoporótica" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0915" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of dual energy X-ray absorptiometry, the trabecular bone score and quantitative computed tomography in the evaluation of chronic kidney disease-mineral and bone disorders" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0920" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Chronic kidney disease and the skeleton" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/boneres.2014.44" "Revista" => array:5 [ …5] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0925" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinician's guide to prevention and treatment of osteoporosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-014-2794-2" "Revista" => array:6 [ …6] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0930" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Renal function and risk of hip and vertebral fractures in older women" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archinte.167.2.133" "Revista" => array:6 [ …6] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0935" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2009.10.049" "Revista" => array:7 [ …7] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0940" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Are currently GFR estimating equations and standard <span class="elsevierStyleItalic">K</span><span class="elsevierStyleInf">t</span>/<span class="elsevierStyleItalic">V</span> value adequate for advanced chronic kidney disease (CKD) frail elderly patients?" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11255-015-1010-4" "Revista" => array:6 [ …6] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0945" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The three-year incidence of fracture in chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ki.2013.547" "Revista" => array:6 [ …6] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0950" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "In elderly men and women treated for osteoporosis a low creatinine clearance of <65<span class="elsevierStyleHsp" style=""></span>ml/min is a risk factor for falls and fractures" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-005-1903-7" "Revista" => array:6 [ …6] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0955" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impaired muscle strength is associated with fractures in hemodialysis patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0960" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vitamin D, a modulator of musculoskeletal health in chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jcsm.12218" "Revista" => array:6 [ …6] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0965" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-013-2524-1" "Revista" => array:6 [ …6] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0970" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of fracture risk prediction among individuals with reduced and normal kidney function" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.06040614" "Revista" => array:6 [ …6] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0975" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "FRAX predicts fracture risk in kidney transplant recipients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.TP.0000438200.84154.1a" "Revista" => array:6 [ …6] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0980" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The FRAX<span class="elsevierStyleSup">®</span> as a predictor of mortality in Japanese incident hemodialysis patients: an observational, follow-up study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00774-014-0631-5" "Revista" => array:6 [ …6] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0985" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probability of fractures predicted by FRAX<span class="elsevierStyleSup">®</span> and observed incidence in the Spanish ECOSAP Study cohort" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.bone.2011.11.006" "Revista" => array:7 [ …7] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0990" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "[The FRAX(<span class="elsevierStyleSup">®</span>) tool in the prevention of fractures associated with androgenic deprivation therapy for prostate cancer]" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0995" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "[FRAX<span class="elsevierStyleSup">®</span> thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population]" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib1000" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aortic calcification and the risk of osteoporosis and fractures" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2003-030964" "Revista" => array:6 [ …6] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib1005" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The association between low bone mass at the menopause and cardiovascular mortality" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib1010" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relationship between osteoporosis and cardiovascular disease in posmenopausal women" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1359/JBMR.050711" "Revista" => array:6 [ …6] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib1015" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease?" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib1020" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Usefulness of bone mineral density to predict significant coronary artery disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2005.06.034" "Revista" => array:6 [ …6] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib1025" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-003-1405-4" "Revista" => array:6 [ …6] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib1030" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Progression of vascular calcifications is associated with greater bone loss and increased bone fractures" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-007-0539-1" "Revista" => array:6 [ …6] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib1035" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Screening and treatment of osteoporosis after hip fracture: comparison of sex and race" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jocd.2014.01.009" "Revista" => array:6 [ …6] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib1040" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vascular calcifications, vertebral fractures and mortality in haemodialysis patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfn466" "Revista" => array:6 [ …6] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib1045" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High prevalence of vertebral fractures assessed by quantitative morphometry in hemodialysis patients, strongly associated with vascular calcifications" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00223-013-9722-x" "Revista" => array:6 [ …6] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib1050" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "From skeletal to cardiovascular disease in 12 steps – the evolution of sclerostin as a major player in CKD–MBD" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00467-015-3069-7" "Revista" => array:6 [ …6] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib1055" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "New conclusions regarding comparison of sevelamer and calcium-based phosphate binders in coronary-artery calcification for dialysis patients: a meta-analysis of randomized controlled trials" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib1060" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "[Prevalence of vertebral fractures and aortic calcifications in hemodialysis patients: comparison with a population of the same age and sex]" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ …7] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib1065" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vascular calcifications: pathogenesis, management, and impact on clinical outcomes" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2006080925" "Revista" => array:7 [ …7] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib1070" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bone metabolism, vascular calcifications and mortality: associations beyond mere coincidence" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib1075" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fractures in chronic kidney disease: pursuing the best screening and management" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MNH.0000000000000131" "Revista" => array:7 [ …7] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib1080" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High rates of death and hospitalization follow bone fracture among hemodialysis patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ki.2013.279." "Revista" => array:6 [ …6] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib1085" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased risk of hip fracture among patients with end-stage renal disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1046/j.1523-1755.2000.00178.x" "Revista" => array:7 [ …7] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib1090" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of hip fracture among dialysis and renal transplant recipients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib1095" "etiqueta" => "67" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased risk of hip fracture among Japanese hemodialysis patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00774-012-0411-z" "Revista" => array:6 [ …6] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib1100" "etiqueta" => "68" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Significant association of fracture of the lumbar spine with mortality in female hemodialysis patients: a prospective observational study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00223-009-9278-y" "Revista" => array:6 [ …6] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib1105" "etiqueta" => "69" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Kidney function and fracture risk: the Atherosclerosis Risk in Communities (ARIC) study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2015.06.020" "Revista" => array:6 [ …6] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib1110" "etiqueta" => "70" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cystatin C and risk of hip fractures in older women" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jbmr.1858" "Revista" => array:6 [ …6] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib1115" "etiqueta" => "71" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Kidney function and fracture risk: the Atherosclerosis Risk in Communities (ARIC) study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2015.06.020" "Revista" => array:6 [ …6] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib1120" "etiqueta" => "72" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The impact of acute kidney injury with temporary dialysis on the risk of fracture" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jbmr.2061" "Revista" => array:6 [ …6] ] ] ] ] ] 72 => array:3 [ "identificador" => "bib1125" "etiqueta" => "73" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Measures of renal function, bone mineral density, bone loss and osteoporotic fracture in older adults: the Rancho Bernardo Study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1359/jbmr.061014" "Revista" => array:6 [ …6] ] ] ] ] ] 73 => array:3 [ "identificador" => "bib1130" "etiqueta" => "74" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Kidney function predicts the rate of bone loss in older individuals: the Cardiovascular Health Study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 74 => array:3 [ "identificador" => "bib1135" "etiqueta" => "75" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Renal function and rate of hip bone loss in older men: the osteoporotic fractures in men study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-008-0608-0" "Revista" => array:6 [ …6] ] ] ] ] ] 75 => array:3 [ "identificador" => "bib1140" "etiqueta" => "76" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Renal function and bone loss in a cohort of Afro-Caribbean men" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jbmr.2562" "Revista" => array:6 [ …6] ] ] ] ] ] 76 => array:3 [ "identificador" => "bib1145" "etiqueta" => "77" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/sj.ki.5001754" "Revista" => array:6 [ …6] ] ] ] ] ] 77 => array:3 [ "identificador" => "bib1150" "etiqueta" => "78" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence and risk factors for hip fractures in dialysis patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-013-2435-1" "Revista" => array:6 [ …6] ] ] ] ] ] 78 => array:3 [ "identificador" => "bib1155" "etiqueta" => "79" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of fracture in adults on renal replacement therapy: a Danish national cohort study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfw073" "Revista" => array:6 [ …6] ] ] ] ] ] 79 => array:3 [ "identificador" => "bib1160" "etiqueta" => "80" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Greater risk of hip fracture in hemodialysis than in peritoneal dialysis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-014-2632-6" "Revista" => array:6 [ …6] ] ] ] ] ] 80 => array:3 [ "identificador" => "bib1165" "etiqueta" => "81" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dementia is a major risk factor for hip fractures in patients with chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-015-3429-y" "Revista" => array:6 [ …6] ] ] ] ] ] 81 => array:3 [ "identificador" => "bib1170" "etiqueta" => "82" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Skeletal fractures in patients on renal replacement therapy: how large still is the knowledge gap?" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfw055" "Revista" => array:6 [ …6] ] ] ] ] ] 82 => array:3 [ "identificador" => "bib1175" "etiqueta" => "83" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/ajkd.2000.19812" "Revista" => array:6 [ …6] ] ] ] ] ] 83 => array:3 [ "identificador" => "bib1180" "etiqueta" => "84" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relationship between moderate to severe kidney disease and hip fracture in the United States" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2005111194" "Revista" => array:6 [ …6] ] ] ] ] ] 84 => array:3 [ "identificador" => "bib1185" "etiqueta" => "85" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vertebral fractures in osteoporosis: a new method for clinical assessment" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 85 => array:3 [ "identificador" => "bib1190" "etiqueta" => "86" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vertebral fractures: clinical importance and management" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 86 => array:3 [ "identificador" => "bib1195" "etiqueta" => "87" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1359/jbmr.091025" "Revista" => array:6 [ …6] ] ] ] ] ] 87 => array:3 [ "identificador" => "bib1200" "etiqueta" => "88" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1515/cclm-2014-0194" "Revista" => array:6 [ …6] ] ] ] ] ] 88 => array:3 [ "identificador" => "bib1205" "etiqueta" => "89" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic significance of the presence of vertebral fractures in the survival of chronic kidney disease patients stages 3–5 not on dialysis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 89 => array:3 [ "identificador" => "bib1210" "etiqueta" => "90" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vertebral morphometry" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rcl.2010.02.018" "Revista" => array:6 [ …6] ] ] ] ] ] 90 => array:3 [ "identificador" => "bib1215" "etiqueta" => "91" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Morphometric X-ray absorptiometry in the assessment of vertebral fractures in renal transplant patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfi206" "Revista" => array:6 [ …6] ] ] ] ] ] 91 => array:3 [ "identificador" => "bib1220" "etiqueta" => "92" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "[Abstract]" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Significado pronóstico de la presencia de fracturas vertebrales en la supervivencia de los pacientes con erc estadios 3–5 no en diálisis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 92 => array:3 [ "identificador" => "bib1225" "etiqueta" => "93" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Chronic kidney disease and hip fracture-related mortality in older people in the UK" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfn678" "Revista" => array:6 [ …6] ] ] ] ] ] 93 => array:3 [ "identificador" => "bib1230" "etiqueta" => "94" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "How to predict and treat increased fracture risk in chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/joim.12361" "Revista" => array:6 [ …6] ] ] ] ] ] 94 => array:3 [ "identificador" => "bib1235" "etiqueta" => "95" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteoporosis III: diagnosis of osteoporosis and assessment of fracture risk" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(02)08761-5" "Revista" => array:6 [ …6] ] ] ] ] ] 95 => array:3 [ "identificador" => "bib1240" "etiqueta" => "96" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD)" ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 96 => array:3 [ "identificador" => "bib1245" "etiqueta" => "97" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.09470913" "Revista" => array:6 [ …6] ] ] ] ] ] 97 => array:3 [ "identificador" => "bib1250" "etiqueta" => "98" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapid cortical bone loss in patients with chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jbmr.1916" "Revista" => array:6 [ …6] ] ] ] ] ] 98 => array:3 [ "identificador" => "bib1255" "etiqueta" => "99" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Changing bone patterns with progression of chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.kint.2015.12.004" "Revista" => array:6 [ …6] ] ] ] ] ] 99 => array:3 [ "identificador" => "bib1260" "etiqueta" => "100" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Low bone mineral density and fractures in stages 3–5 CKD: an updated systematic review and meta-analysis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-014-2813-3" "Revista" => array:6 [ …6] ] ] ] ] ] 100 => array:3 [ "identificador" => "bib1265" "etiqueta" => "101" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jocd.2015.06.013" "Revista" => array:6 [ …6] ] ] ] ] ] 101 => array:3 [ "identificador" => "bib1270" "etiqueta" => "102" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bone mineral density predicts fractures in chronic kidney disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jbmr.2406" "Revista" => array:6 [ …6] ] ] ] ] ] 102 => array:3 [ "identificador" => "bib1275" "etiqueta" => "103" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 103 => array:3 [ "identificador" => "bib1280" "etiqueta" => "104" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Arteriovenous fistula affects bone mineral density measurements in end-stage renal failure patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.01470209" "Revista" => array:6 [ …6] ] ] ] ] ] 104 => array:3 [ "identificador" => "bib1285" "etiqueta" => "105" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients-a single-center cohort study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfr317" "Revista" => array:6 [ …6] ] ] ] ] ] 105 => array:3 [ "identificador" => "bib1290" "etiqueta" => "106" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bone mineral density and fracture risk in older individuals with CKD" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.12871211" "Revista" => array:6 [ …6] ] ] ] ] ] 106 => array:3 [ "identificador" => "bib1295" "etiqueta" => "107" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Trabecular bone score and incident fragility fracture risk in adults with reduced kidney function" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 107 => array:3 [ "identificador" => "bib1300" "etiqueta" => "108" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 108 => array:3 [ "identificador" => "bib1305" "etiqueta" => "109" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 109 => array:3 [ "identificador" => "bib1310" "etiqueta" => "110" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 110 => array:3 [ "identificador" => "bib1315" "etiqueta" => "111" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 111 => array:3 [ "identificador" => "bib1320" "etiqueta" => "112" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 112 => array:3 [ "identificador" => "bib1325" "etiqueta" => "113" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 113 => array:3 [ "identificador" => "bib1330" "etiqueta" => "114" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 114 => array:3 [ "identificador" => "bib1335" "etiqueta" => "115" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "Available at: <a class="elsevierStyleInterRef" target="_blank" id="intr0025" href="http://www.semg.es/images/stories/recursos/2015/documentos/osteoporosis_guia.pdf">http://www.semg.es/images/stories/recursos/2015/documentos/osteoporosis_guia.pdf</a> [accessed 19.12.17]" "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 115 => array:3 [ "identificador" => "bib1340" "etiqueta" => "116" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 116 => array:3 [ "identificador" => "bib1345" "etiqueta" => "117" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "Available at: <a class="elsevierStyleInterRef" target="_blank" id="intr0030" href="https://doi.org/10.1016/j.nefro.2017.04.002">https://doi.org/10.1016/j.nefro.2017.04.002</a> [accessed 20.12.17]" "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 117 => array:3 [ "identificador" => "bib1350" "etiqueta" => "118" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 118 => array:3 [ "identificador" => "bib1355" "etiqueta" => "119" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 119 => array:3 [ "identificador" => "bib1360" "etiqueta" => "120" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 120 => array:3 [ "identificador" => "bib1365" "etiqueta" => "121" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 121 => array:3 [ "identificador" => "bib1370" "etiqueta" => "122" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 122 => array:3 [ "identificador" => "bib1375" "etiqueta" => "123" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 123 => array:3 [ "identificador" => "bib1380" "etiqueta" => "124" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 124 => array:3 [ "identificador" => "bib1385" "etiqueta" => "125" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 125 => array:3 [ "identificador" => "bib1390" "etiqueta" => "126" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 126 => array:3 [ "identificador" => "bib1395" "etiqueta" => "127" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 127 => array:3 [ "identificador" => "bib1400" "etiqueta" => "128" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 128 => array:3 [ "identificador" => "bib1405" "etiqueta" => "129" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 129 => array:3 [ "identificador" => "bib1410" "etiqueta" => "130" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 130 => array:3 [ "identificador" => "bib1415" "etiqueta" => "131" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 131 => array:3 [ "identificador" => "bib1420" "etiqueta" => "132" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 132 => array:3 [ "identificador" => "bib1425" "etiqueta" => "133" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 133 => array:3 [ "identificador" => "bib1430" "etiqueta" => "134" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 134 => array:3 [ "identificador" => "bib1435" "etiqueta" => "135" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 135 => array:3 [ "identificador" => "bib1440" "etiqueta" => "136" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 136 => array:3 [ "identificador" => "bib1445" "etiqueta" => "137" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 137 => array:3 [ "identificador" => "bib1450" "etiqueta" => "138" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 138 => array:3 [ "identificador" => "bib1455" "etiqueta" => "139" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 139 => array:3 [ "identificador" => "bib1460" "etiqueta" => "140" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 140 => array:3 [ "identificador" => "bib1465" "etiqueta" => "141" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 141 => array:3 [ "identificador" => "bib1470" "etiqueta" => "142" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 142 => array:3 [ "identificador" => "bib1475" "etiqueta" => "143" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 143 => array:3 [ "identificador" => "bib1480" "etiqueta" => "144" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 144 => array:3 [ "identificador" => "bib1485" "etiqueta" => "145" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 145 => array:3 [ "identificador" => "bib1490" "etiqueta" => "146" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 146 => array:3 [ "identificador" => "bib1495" "etiqueta" => "147" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "[Electronic publication]" "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 147 => array:3 [ "identificador" => "bib1500" "etiqueta" => "148" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 148 => array:3 [ "identificador" => "bib1505" "etiqueta" => "149" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 149 => array:3 [ "identificador" => "bib1510" "etiqueta" => "150" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 150 => array:3 [ "identificador" => "bib1515" "etiqueta" => "151" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 151 => array:3 [ "identificador" => "bib1520" "etiqueta" => "152" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack375806" "titulo" => "Acknowledgements" "texto" => "<p id="par0195" class="elsevierStylePara elsevierViewall">This review includes authors who belong to the <span class="elsevierStyleItalic">Red Nacional RedinRen</span> [<span class="elsevierStyleGrantSponsor" id="gs1">National Kidney Research Network</span>] (<span class="elsevierStyleGrantNumber" refid="gs1">RD06/0016/0001</span> and <span class="elsevierStyleGrantNumber" refid="gs1">RD12/0021/0033</span>), the <span class="elsevierStyleItalic">Red de Biobancos Nacional Española</span> [<span class="elsevierStyleGrantSponsor" id="gs2">Spanish National Biobank Network</span>] (<span class="elsevierStyleGrantNumber" refid="gs2">RD09/0076/00064</span>) and the <span class="elsevierStyleItalic">Grupo Catalán de Investigación</span> [<span class="elsevierStyleGrantSponsor" id="gs3">Catalan Research Group AGAUR</span>] (<span class="elsevierStyleGrantNumber" refid="gs3">2009 SGR-1116</span>), as well as contributors from the <span class="elsevierStyleItalic">Fundación Iñigo Álvarez de Toledo</span> [Iñigo Álvarez de Toledo Foundation] (<span class="elsevierStyleGrantSponsor" id="gs4">FRIAT</span>). We also wish to thank Ricardo Pellejero for his help with the literature references.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003800000005/v1_201811140611/S2013251418301123/v1_201811140611/en/main.assets" "Apartado" => array:4 [ "identificador" => "35443" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Reviews" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003800000005/v1_201811140611/S2013251418301123/v1_201811140611/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418301123?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 18 | 12 | 30 |
2024 October | 102 | 53 | 155 |
2024 September | 121 | 42 | 163 |
2024 August | 101 | 90 | 191 |
2024 July | 80 | 29 | 109 |
2024 June | 119 | 55 | 174 |
2024 May | 90 | 32 | 122 |
2024 April | 105 | 54 | 159 |
2024 March | 120 | 35 | 155 |
2024 February | 113 | 62 | 175 |
2024 January | 92 | 37 | 129 |
2023 December | 148 | 35 | 183 |
2023 November | 142 | 61 | 203 |
2023 October | 213 | 49 | 262 |
2023 September | 459 | 57 | 516 |
2023 August | 514 | 42 | 556 |
2023 July | 530 | 51 | 581 |
2023 June | 246 | 43 | 289 |
2023 May | 187 | 64 | 251 |
2023 April | 186 | 42 | 228 |
2023 March | 231 | 46 | 277 |
2023 February | 165 | 51 | 216 |
2023 January | 131 | 60 | 191 |
2022 December | 175 | 63 | 238 |
2022 November | 129 | 64 | 193 |
2022 October | 176 | 61 | 237 |
2022 September | 160 | 70 | 230 |
2022 August | 122 | 65 | 187 |
2022 July | 137 | 78 | 215 |
2022 June | 139 | 84 | 223 |
2022 May | 206 | 80 | 286 |
2022 April | 171 | 86 | 257 |
2022 March | 187 | 91 | 278 |
2022 February | 198 | 71 | 269 |
2022 January | 461 | 95 | 556 |
2021 December | 200 | 66 | 266 |
2021 November | 185 | 74 | 259 |
2021 October | 196 | 102 | 298 |
2021 September | 156 | 80 | 236 |
2021 August | 151 | 63 | 214 |
2021 July | 186 | 83 | 269 |
2021 June | 176 | 74 | 250 |
2021 May | 148 | 68 | 216 |
2021 April | 449 | 198 | 647 |
2021 March | 238 | 80 | 318 |
2021 February | 178 | 89 | 267 |
2021 January | 199 | 37 | 236 |
2020 December | 189 | 58 | 247 |
2020 November | 154 | 39 | 193 |
2020 October | 129 | 54 | 183 |
2020 September | 163 | 64 | 227 |
2020 August | 120 | 45 | 165 |
2020 July | 118 | 30 | 148 |
2020 June | 151 | 46 | 197 |
2020 May | 246 | 63 | 309 |
2020 April | 178 | 61 | 239 |
2020 March | 270 | 44 | 314 |
2020 February | 303 | 71 | 374 |
2020 January | 260 | 93 | 353 |
2019 December | 196 | 58 | 254 |
2019 November | 207 | 75 | 282 |
2019 October | 212 | 96 | 308 |
2019 September | 215 | 85 | 300 |
2019 August | 173 | 51 | 224 |
2019 July | 98 | 53 | 151 |
2019 June | 197 | 71 | 268 |
2019 May | 140 | 70 | 210 |
2019 April | 123 | 88 | 211 |
2019 March | 72 | 60 | 132 |
2019 February | 56 | 40 | 96 |
2019 January | 93 | 60 | 153 |
2018 December | 168 | 65 | 233 |
2018 November | 349 | 31 | 380 |
2018 October | 15 | 1 | 16 |